Singapore markets closed

Straits Times Index
3,331.70
+5.42(+0.16%)
S&P 500
5,465.31
-3.99(-0.07%)
Dow
38,949.04
-163.12(-0.42%)
Nasdaq
17,770.68
+53.02(+0.30%)
Bitcoin USD
61,811.02
+565.59(+0.92%)
CMC Crypto 200
1,280.34
-3.45(-0.27%)

ITCI Jun 2024 60.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

15.80

-1.80

(-10.23%)

As of 02:18PM EDT. Market open.

Zacks
Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe
Intra-Cellular (ITCI) is witnessing strong Caplyta sales, driven by an increasing prescription rate. However, the company is heavily dependent on Caplyta sales for growth, which is a concern.
Zacks
Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News
Intra-Cellular Therapies (ITCI) and Zentalis Pharmaceuticals, Inc. (ZNTL) are in the spotlight following pipeline and regulatory updates, respectively.
Zacks
Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals
Intra-Cellular (ITCI) gains 10% after achieving key goals in the second late-stage study evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of MDD.